Bank of Montreal
KYMR icon

Bank of Montreal’s Kymera Therapeutics KYMR Stock Holding History

Bank of Montreal’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-59,370
Closed -$1.18K – 4257
2022
Q2 		$1.18K Buy
+59,370
New +$1.39M ﹤0.01% 2207
2021
Q4 		– Sell
-174,027
Closed -$10.2M – 3698
2021
Q3 		$10.2M Buy
+174,027
New +$10.1M ﹤0.01% 1283
2021
Q2 		– Sell
-454
Closed -$16K – 4341
2021
Q1 		$16K Sell
454
-1,119
-71% -$67.4K ﹤0.01% 4149
2020
Q4 		$120K Buy
+1,573
New +$76.7K ﹤0.01% 3490

Other funds holding KYMR

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bank of Montreal's KYMR Position: Q3 2022 in Review

Bank of Montreal sold out of Kymera Therapeutics (KYMR) in Q3 2022, closing a stake of 59,370 shares — an estimated $1.18K sold.

Bank of Montreal first reported a position in KYMR in Q4 2020 and held it in 4 quarters. The position peaked at $10.2M in Q3 2021. 127 funds tracked by Wall St. Rank hold KYMR as of Q3 2022.

  • Bank of Montreal reported no remaining Kymera Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 59,370 Kymera Therapeutics shares in Q3 2022, an estimated $1.18K.
  • Bank of Montreal first reported a position in Kymera Therapeutics in Q4 2020 and held it in 4 quarters.
  • Bank of Montreal's Kymera Therapeutics position peaked at $10.2M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.